PEER

The Patient Engagement and Equity Report (PEER) was developed by patient service experts with the goal of providing the biopharma industry and PAGs specializing in cancer and rare diseases benchmarking data and qualitative information about their organizations and industry reputation. 

As the needs of the patient community continue to change at an accelerated pace, it is critically important that the partnership between industry and the patient communities is built of a key two-way understanding of the core areas of focus and the key priorities of stakeholders engaged in cancer and rare disease. 

Additionally, greater two-way transparent exchange of performance and reputation-related information is the foundation for building more productive collaborations between PAGs and industry.

  The advocacy-industry partnership is an incredibly important part of the ecology of cancer care in this country, and with their focus on advocacy and service they can help make it a bit more certain that the care and support we need is there at a time when many need it more than ever.